Pacific Biosciences Of California Revenue 2010-2023 | PACB

Pacific Biosciences Of California revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Pacific Biosciences Of California Annual Revenue
(Millions of US $)
2023 $201
2022 $128
2021 $131
2020 $79
2019 $91
2018 $79
2017 $93
2016 $91
2015 $93
2014 $61
2013 $28
2012 $26
2011 $34
2010 $2
2009 $0
Pacific Biosciences Of California Quarterly Revenue
(Millions of US $)
2023-12-31 $58
2023-09-30 $56
2023-06-30 $48
2023-03-31 $39
2022-12-31 $27
2022-09-30 $32
2022-06-30 $35
2022-03-31 $33
2021-12-31 $36
2021-09-30 $35
2021-06-30 $31
2021-03-31 $29
2020-12-31 $27
2020-09-30 $19
2020-06-30 $17
2020-03-31 $16
2019-12-31 $28
2019-09-30 $22
2019-06-30 $25
2019-03-31 $16
2018-12-31 $20
2018-09-30 $18
2018-06-30 $22
2018-03-31 $19
2017-12-31 $25
2017-09-30 $24
2017-06-30 $20
2017-03-31 $25
2016-12-31 $26
2016-09-30 $25
2016-06-30 $21
2016-03-31 $19
2015-12-31 $36
2015-09-30 $14
2015-06-30 $25
2015-03-31 $18
2014-12-31 $17
2014-09-30 $21
2014-06-30 $11
2014-03-31 $12
2013-12-31 $9
2013-09-30 $7
2013-06-30 $6
2013-03-31 $6
2012-12-31 $6
2012-09-30 $3
2012-06-30 $7
2012-03-31 $10
2011-12-31 $12
2011-09-30 $11
2011-06-30 $11
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $1
2010-03-31 $1
2009-12-31
2009-09-30
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.607B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.045B 27.51
Intuitive Surgical (ISRG) United States $136.272B 82.09
Edwards Lifesciences (EW) United States $52.101B 33.91
DexCom (DXCM) United States $50.096B 75.89
Alcon (ALC) Switzerland $44.024B 31.55
IDEXX Laboratories (IDXX) United States $43.037B 50.45
IQVIA Holdings (IQV) United States $42.114B 24.43
STERIS (STE) Ireland $23.320B 27.25
Waters (WAT) United States $21.295B 31.30
SONOVA HOLDING (SONVY) Switzerland $18.860B 0.00
Hologic (HOLX) United States $17.655B 19.75
Fresenius Medical Care AG KGaA (FMS) Germany $12.898B 15.06
ShockWave Medical (SWAV) United States $12.427B 77.34
Sysmex ADR (SSMXY) Japan $10.938B 34.30
Teleflex (TFX) United States $10.015B 15.59
Globus Medical (GMED) United States $8.507B 24.94
Penumbra (PEN) United States $8.091B 91.95
Masimo (MASI) United States $6.118B 35.24
Glaukos (GKOS) United States $5.589B 0.00
TransMedics (TMDX) United States $4.362B 413.88
Integer Holdings (ITGR) United States $3.753B 22.67
PROCEPT BioRobotics (PRCT) United States $3.359B 0.00
LivaNova (LIVN) United Kingdom $3.327B 19.75
Elekta AB (EKTAY) Sweden $2.883B 19.78
Tandem Diabetes Care (TNDM) United States $2.846B 0.00
Inari Medical (NARI) United States $2.645B 0.00
Nihon Kohden (NHNKY) Japan $2.489B 21.05
RxSight (RXST) United States $2.227B 0.00
Integra LifeSciences Holdings (IART) United States $2.083B 9.09
Veracyte (VCYT) United States $1.760B 0.00
Alphatec Holdings (ATEC) United States $1.521B 0.00
Artivion (AORT) United States $0.977B 93.76
AVANOS MEDICAL, INC (AVNS) United States $0.922B 17.94
OPKO Health (OPK) United States $0.910B 0.00
Silk Road Medical (SILK) United States $0.832B 0.00
OrthoPediatrics (KIDS) United States $0.746B 0.00
Paragon 28 (FNA) United States $0.659B 0.00
Mesa Laboratories (MLAB) United States $0.637B 21.63
SiBone (SIBN) United States $0.604B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.566B 0.00
IRadimed (IRMD) United States $0.536B 29.99
Pulse Biosciences (PLSE) United States $0.425B 0.00
Nevro (NVRO) United States $0.363B 0.00
Tactile Systems Technology (TCMD) United States $0.324B 11.08
Treace Medical Concepts (TMCI) United States $0.310B 0.00
Sight Sciences (SGHT) United States $0.271B 0.00
EDAP TMS S.A (EDAP) France $0.256B 0.00
AxoGen (AXGN) United States $0.252B 0.00
AngioDynamics (ANGO) United States $0.247B 0.00
908 Devices (MASS) United States $0.247B 0.00
NeuroPace (NPCE) United States $0.245B 0.00
Inogen (INGN) United States $0.210B 0.00
Delcath Systems (DCTH) United States $0.196B 0.00
Atossa Genetics (ATOS) United States $0.194B 0.00
Alpha Tau Medical (DRTS) Israel $0.184B 0.00
CVRx (CVRX) United States $0.167B 0.00
Semler Scientific (SMLR) United States $0.166B 8.42
ClearPoint Neuro (CLPT) United States $0.165B 0.00
Accuray (ARAY) United States $0.159B 0.00
KORU Medical Systems (KRMD) United States $0.106B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Yubo Biotech (YBGJ) China $0.100B 0.00
Sensus Healthcare (SRTS) United States $0.087B 18.28
Neuronetics (STIM) United States $0.072B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Monogram Orthopaedics (MGRM) United States $0.064B 0.00
SEP Acquisition (SEPA) United States $0.064B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Envoy Medical (COCH) United States $0.060B 0.00
InspireMD (NSPR) Israel $0.059B 0.00
DarioHealth (DRIO) United States $0.051B 0.00
Autonomix Medical (AMIX) United States $0.051B 0.00
Vasomedical (VASO) United States $0.050B 9.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.045B 0.00
ReWalk Robotics (LFWD) Israel $0.044B 0.00
Pixie Dust Technologies (PXDT) Japan $0.037B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Aspira Women's Health (AWH) United States $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.035B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.026B 0.00
T2 Biosystems (TTOO) United States $0.023B 0.00
PAVmed (PAVM) United States $0.021B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
Biosig Technologies (BSGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.014B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00